Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Advanced Renal Cancer × Sunitinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Renal Cell 6 Gastrointestinal Stromal Tumors 3 Urologic Neoplasms 2 Carcinoma 2 Uveal Melanoma 1 Sarcoma 1 Prostatic Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma 1 Kidney Neoplasms 1 Kidney Diseases 1 Advanced Renal Cancer 1 Advanced Rare Tumours 1

Interventions

anlotinib 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04523272 2024-10-15

A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 3 Active not recruiting

Advanced Renal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡